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described the “explosion” of mitotic figures observed
in tissues of colchicine-treated plants and animals (re-
viewed in [3]). Although we now understand that this
arises from the arrest of the normal cell division cycle
in mitosis, it was initially considered that colchicine
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could be inducing an altered mitosis in treated tissues
that was called “c-mitosis.” In plants, colchicine proved
a rapid and convenient tool to generate agriculturallyChemical inhibitors, whether natural products or syn-
important polyploid strains, quickly replacing previousthetic, have had an enormous impact on the study
methods such as heat shock or treatment with otherof the eukaryotic cytoskeleton. Here we review the
chemicals (extensively reviewed in [2]). In addition, thehistory of some of the most widely used cytoskeletal
increased prevalence of mitotic figures in colchicine-poisons and their influence on our understanding of
treated cells was used to unambiguously determine thatcytoskeletal functions. We then highlight several new
46 chromosomes is the normal human diploid numberinhibitors and the targeted screens used to identify
rather than the previously believed 48 [3, 4]. Thus, eventhem and discuss why this approach has been suc-
prior to the identification of the mechanism of action ofcessful.
colchicine, it was widely used in the areas of medicine,
agriculture, and biology.Introduction
The determination of tubulin as the protein target ofFew problems in biology have seen such a strong impact
colchicine by Ed Taylor and colleagues in the late 1960sfrom the development of small molecule tools as the
stands as a landmark in the identification of small mole-study of cell morphogenesis and the subsequent eluci-
cule targets in complex mixtures as well as opening updation of the underlying anatomy of the cell that we
the microtubule field by identifying the protein subunitnow call the cytoskeleton. Compounds targeting the
that comprises these filaments. Using radiolabeled col-cytoskeleton are among the most commonly used
chicine prepared by methylation of colchiceine in triti-chemical inhibitors in basic cell biological research. In
ated water, Borisy and Taylor biochemically character-addition, several of these have been developed into
ized a colchicine binding activity in both intact cells andbona fide drugs widely used in the treatment of such
cell extracts [5, 6, 7]. This binding activity was found todiseases as cancers and gout. The goal of this review
be enriched in cells and tissues containing abundantis to briefly review the history of a few of the most
microtubules, suggesting that the target of colchicinecommon inhibitors of the cytoskeleton with an emphasis
was the subunit of microtubules. Taylor and colleagueson the impact these molecules had and continue to have
subsequently purified the colchicine binding proteinon this field. By “impact,” we mean either a significant
from both sperm tails and mammalian brain and charac-conceptual leap in our understanding or a novel tech-
terized it as a 120 kDa dimer containing 2 moles ofnique that becomes widely used. We will then highlight
bound GTP, thus identifying the molecular subunit ofa few recent examples of novel small molecule inhibitors
microtubules [8, 9]. The name “tubulin” was providedidentified in screens targeting the cytoskeleton and dis-
by Mohri [10], who determined the amino acid composi-cuss the promise that chemical approaches offer for the
tion of the sea urchin sperm microtubule subunit. Thus,future of research on the cytoskeleton.
colchicine was at the same time the agent for tying
microtubules to important cellular processes such as
Colchicine and the Identification of Tubulin mitosis and the agent of protein (gene) discovery, fulfill-
The identification of the target of colchicine as tubulin, ing the requirements of forward chemical genetics.
the subunit comprising the ubiquitous microtubule cy-
toskeleton of cells, is a remarkable example of forward Taxol and Nocodazole
chemical genetics. Indeed, the discovery of tubulin is In 1971, a natural product with antileukemic and antitu-
intimately tied to the identification of the colchicine tar- mor activity was identified from an alcohol extract of
get. This tropolone derivative, found in the meadow saf- the bark of the western yew (Taxus brevifolia) and named
fron (genus Colchicum), has been used medicinally taxol [11]. Progress on taxol lagged due to its perceived
since at least the 18th century (and continues to be low antitumor activity, the limited quantities of the com-
used) in the treatment of gout, and it is widely used as pound, and scarcity of the source tree [12, 13]. Neverthe-
a research tool for the study of microtubules. Only in less, later observation of cells isolated from taxol-
1940 was the structure of the active component, colchi- treated mice revealed the presence of abnormal mitotic
cine, determined [1], and by the 1950s the effects of figures [14]. Remarkably, in contrast to other microtu-
colchicine had been studied in cells and tissues of many bule poisons (colchicine, nocodazole, the Vinca alka-
types (for a comprehensive review of the early history loids, eg.), taxol was shown to stimulate the polymeriza-
of colchicine, see [2]). tion of microtubules both in vitro [15] and in vivo [16,
Early investigation of the cellular effects of colchicine 17]. With this discovery, then, two distinct natural prod-
ucts had been identified with opposing activities on mi-
crotubule stability.1Correspondence: jeffrey_peterson@hms.harvard.edu
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Figure 1. Use of Taxol-Stabilized Microtubules for the Isolation of
MAPs
Richard Vallee isolated microtubule-associated proteins by adding
taxol to induce the polymerization and stabilization of microtubules
in a soluble extract of bovine brain. Taxol-stabilized microtubules
were subsequently stripped of their associated proteins in a high-
salt wash and pelleted, leaving the isolated MAPs in the superna-
tant [18].
The subsequent impact of taxol on basic biological Figure 2. Structure and Effect of Classical Microtubule Poisons
research was dramatic. Vallee [18] exploited the strong In the upper panels, B-SC-1 cells treated with 2 M colcemid or 10
stabilizing influence of taxol on microtubules to purify M taxol for 1 hr were fixed and stained with anti-tubulin antibodies
(green), and DNA was stained with Hoechst (blue). In the lowerthem and their bound microtubule-associated proteins
panels, B-SC-1 cells treated for 24 hr with 3.3 M nocodazole or(MAPs) from bovine brain (see Figure 1). Taxol was
vehicle control were stained with Hoechst. Note the increased prev-added to an extract of brain to polymerize microtubules
alence of mitotic nuclei containing condensed DNA (several exam-
and allow binding of endogenous MAPs. These fila- ples are marked with arrowheads).
ments were then centrifuged and collected. A subse-
quent high-salt wash of the pellet stripped the MAPs,
while the constant presence of taxol maintained the name nocodazole, and this term has endured to the
present, perhaps because the early clinical promisestructural integrity of the microtubules, which could then
be centrifuged away from the soluble MAPs. Thus, taxol against cancer was not realized. As with taxol, the micro-
tubule disruption observed in nocodazole-treated cellsallowed an affinity-based purification of MAPs that, be-
cause of the instability of microtubules to the high-salt led researchers to test directly if nocodazole bound to
tubulin. De Brabander and colleagues showed that no-extraction, would not have been possible otherwise. A
similar microtubule affinity purification using taxol later codazole indeed bound tubulin and in a manner compet-
itive with colchicine [21].aided the discovery and study of the microtubule-based
motor protein kinesin [19]. Taxol-stabilized microtubules
have also been used as the substrate to visualize gliding What Have We Learned from
Microtubule Poisons?motility powered by both major microtubule-based mo-
tor families, kinesin and dynein, immobilized on glass Immunofluorescence staining using anti-tubulin anti-
bodies reveals a dramatic disruption of the microtubulecoverslips.
A synthetic compound directly affecting microtubules network in cells treated with microtubule poisons (Figure
2). Nocodazole along with colchicine have been usedwas identified in Belgium (Janssen Pharmaceutica) in
1975 in a screen for antihelminthic compounds and was to demonstrate functional roles for microtubules in nu-
merous cell biological processes, including the anchor-termed oncodazole (R 17934), presumably for an ob-
served antitumor activity [20]. Two years later, this benz- ing of the Golgi complex at the microtubule-organizing
center (reviewed in [22]), cell migration, and tumor inva-imidazole compound appears in the literature by the
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sion (reviewed in [23]). Nocodazole is preferred over genes critical for ensuring the proper temporal order
of cell cycle events, and understanding their functioncolchicine in basic research when reversible inhibition of
microtubule polymerization is required. The dissociation remains a central question in cell biology.
Their usefulness in arresting cell division has led torate of colchicine from tubulin is very slow [6], which
helped in the identification of tubulin by Taylor and col- the assessment of many microtubule inhibitors for the
treatment of cancer. Indeed, the microtubule-destabiliz-leagues.
An additional role for microtubules uncovered with ing Vinca alkaloids vinblastine (originally vincaleuko-
blastine [32]) and vincristine helped establish a link be-the help of microtubule-disrupting agents is the traffick-
ing of intracellular particles. The microtubule cytoskele- tween microtubules and cancer. These closely related
but chemically distinct compounds from leaves of theton is generally arrayed from a central organizing center
termed the MTOC from which microtubules radiate Madagascar periwinkle were originally isolated based
on their ability to depress white blood cell counts (re-throughout the cell (see Figure 2). Melanophores utilize
this microtubule “highway” for the intracellular distribu- viewed in [33]). This original observation has now ma-
tured into the current use of vinblastine and vincristinetion of thousands of pigment granules that migrate along
this network using microtubule-based motors. The dis- in the clinical treatment of Hodgkin’s lymphoma and
leukemia, respectively. The development and history ofpersion of granules to the cell periphery produces an
apparent “darkening” in the skin, whereas the aggrega- microtubule poisons for clinical use is outside the scope
of this review, however, and the interested reader istion of granules at the MTOC produces the opposite
effect. In 1965, prior to the identification of tubulin, Ste- referred to any of a number of reviews (e.g., [32, 12,
34]). Nevertheless, it deserves mentioning that taxol,phen Malawista [24] demonstrated that colchicine per-
turbed the aggregation of frog melanocyte granules, colchicine, and the Vinca alkaloids are mature, modern
pharmaceuticals and, because of the central role of thewhich he interpreted in terms of a “decreased protoplas-
mic viscosity.” Once the target of colchicine had been cytoskeleton in cell division, cytoskeletal proteins re-
main important anticancer targets [35]. Indeed, the nextidentified, subsequent work using colchicine and the
Vinca alkaloids helped demonstrate that microtubules generation of tubulin-targeting, anticancer compounds
is being developed to address limitations of the currentplay a fundamental role in the movement of pigment
granules (reviewed in [25, 26]). The importance of micro- arsenal, such as aqueous solubility, multidrug resis-
tance, and the pronounced toxicity toward lymphocytestubules to the intracellular transport of other organelles
and vesicles remains an important question in cell and peripheral neurons. One well-characterized exam-
ple, the natural product epothilone, stabilizes microtu-biology.
bules with greater potency than taxol, is less sensitive
than taxol to P-glycoprotein-mediated multidrug resis-
The Cell Cycle, Checkpoints, and Cancer tance, and remains active against taxol-resistant tumor
Since taxol, nocodazole, and the colchicine relative models (reviewed in [36, 37]). Several total syntheses of
colcemid all block normal chromosome segregation, epothilone have been achieved, and medicinal chemis-
Schimke and coworkers tested the affect of microtubule try efforts have identified derivatives with improved
disruption by these agents on cell cycle progression of pharmacological properties (reviewed in [38, 39]). Read-
numerous mammalian cell lines [27]. The authors ob- ers interested in a more comprehensive and mechanistic
served that human cell lines generally arrested in mitosis view of small molecules that target tubulin and their
in compound-treated cells, consistent with the postulate anticancer potential are directed to other reviews (see
of a checkpoint that ensures that cells remain in mitosis [23, 40]). Those interested in recent developments in the
until a proper spindle is assembled [28]. Indeed, inhibi- chemistry of taxol are referred to [41].
tion of cell cycle progression is one of the most promi-
nent features of cells treated with microtubule poisons, Cytochalasins, Phalloidin, and
although cell lines vary in the effectiveness of this arrest the Actin Cytoskeleton
[29]. The mitotic arrest induced by these compounds The family of mold metabolites known as cytochalasins
also provides a convenient manner to synchronize the were independently isolated from distinct fungal species
cell cycle state of cultured cells. Cultured cells treated by Aldridge et al. [42] at Imperial Chemical Industries
with microtubule-depolymerizing agents accumulate in Ltd. and by Rothweiler and Tamm at the University of
mitosis (see Figure 2, lower panels) and can be synchro- Basel [43]. Whereas Rothweiler and Tamm called their
nously released by removing the compound from the compound Phomin after the Phoma species from which
media. This feature is now widely exploited by those they isolated the compound, Carter [44] provided the
studying mitosis for the isolation of cells homoge- name cytochalasin from the Greek cytos (a cell) and
neously arrested in the mitotic state. chalasis (relaxation) to describe the effects of this com-
Benomyl, an agricultural fungicide and microtubule- pound on mouse fibroblasts. A preliminary article based
polymerization inhibitor structurally related to nocoda- on the work at ICI appeared in New Scientist, calling this
zole, was used in a similar manner to explore this check- compound family “one of the most remarkable groups of
point genetically in the yeast Saccharomyces cerevisiae biologically active substances to be described in years,”
[30, 31]. Both groups identified yeast mutants that did although perplexingly the name was spelled “cytocho-
not properly arrest cell cycle progression in response to lasins” [45]. Cytochalasin inhibited whole-cell migration,
disruption of microtubules by benomyl. These mutants, ruffling of the cell margin, and cytoplasmic cleavage
termed “bub” for “budding uninhibited by benomyl” and of dividing cells, but nuclear division continued, thus
producing multinucleated cells over time.“mad” for “mitotic arrest deficient,” identified several
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Carter, knowing nothing about the target of cytocha- animal fibroblasts as well as epidermal and epithelial
lasin, used this compound to probe two important bio- cells suggested that these nonmuscle microfilaments
logical questions: how do cells migrate and how do cells could be related to muscle actin. Similar observations
divide? Having recently proposed a mechanism for cell in Acanthamoeba [56], epithelial brush border [57],
motility based on surface tension and differential adhe- Dictyostelium [58], Physarum [59], and Amoeba [60]
sion of cells to substrates, which he termed ‘haptotaxis’ supported the universiality of these structures. These
[46], it is not surprising that he wrongly interpreted the studies, as well as the biochemical characterization of
effects of cytochalasin on cell motility in terms of the actin-like filaments derived from nonmuscle cells, sup-
compound increasing the adhesivity of the cell mem- ported the ubiquity of actin. Still, the connection be-
brane to the substrate, thus preventing both forward tween these microfilaments, the filaments of the cytoki-
movement and cell ruffling. Nevertheless, using cyto- netic furrow, and the actin filaments of muscle was
chalasin he was able to imply a common molecular tenuous.
mechanism underlying cell ruffling, motility, and cytoki- Wessells and coworkers studied the effects of cyto-
nesis. Furthermore, this motility was distinguishable chalasin and the microtubule inhibitor colchicine, whose
from the movement of spermatozoa, ciliates, and flagel- target had been recently identified, on axonal outgrowth
lates, which were not affected by cytochalasin and are of cultured neurons [61]. They noted that cytochalasin
now known to be actin-independent phenomena. Cyto- rapidly disrupted microspikes and growth cone dynam-
chalasin represented the first compound that could dis- ics, whereas colchicine only affected the axon and on
rupt cytokinesis (cell division) without affecting karyoki- a much slower time scale. These important observations
nesis (nuclear division), thus clearly establishing the suggested a strong connection between the microfila-
independence of karyokinesis from cytokinesis. The ments and growth cone motility while establishing an
usefulness of a specific inhibitor for studying the mecha- important but distinct role for the microtubule system
nism of cytokinesis had already been anticipated by in axonal outgrowth. Similarly, work using cytochalasin
Wolpert [47]. on the glands of the oviduct and salivary epithelium
In order to understand the impact of cytochalasin in showed that disruption of the microfilament network
this area, it is necessary to review contemporary theo- strongly perturbed gland morphogenesis [62, 63].
ries on the mechanism of cell cleavage. Previously, nu- Mounting evidence seemed to suggest that the microfil-
merous ideas had been proposed to explain cytokinesis aments themselves were the target of cytochalasin:
(reviewed in [47]). One of these, the cortical gel contrac-
tion hypothesis [48], proposed that contraction of a cor- The following processes are sensitive to cytochalasin:
tical network underlying the deepening cleavage furrow cytokinesis, cell movement, axonal growth cone and mi-
between daughter cells provided the force for cytokine- crospike activity, maintenance and change in shape of
sis. This model stood in opposition to surface expansion salivary gland epithelium, formation and maintenance of
early glands in oviduct, and perhaps migration of nucleitheories which suggested that plasma membrane
in an epithelium preparatory to mitosis. Every such caseexpansion was an active process providing the energy
can be explained if contractile filaments are renderedfor furrow ingression [49] or theories in which the mitotic
inoperative by the drug; and in every case so far exam-apparatus itself or other subcortical components are
ined, morphological alterations in microfilaments haveresponsible for force generation [50, 51].
resulted from application of cytochalasin. …The com-Despite its postulate of a cortical gel composed of
mon sensitivity to cytochalasin suggests a homology
interlinked “elongate protein components” that could between those filaments comparable to that between
undergo a “forcible folding without relinquishing their microtubules from varying cell types in their sensitivity
intermolecular linkages” during contraction [48], the cor- to colchicine [63].
tical contraction theory lacked a morphological struc-
ture that could be pointed to as the source of force.
The final demonstration that cytochalasin targets the
Using electron microscopy, several investigators subse-
microfilaments directly arrived in 1972. Parallels be-quently identified circumferential filaments underlying
tween the contractile ring and contraction in musclethe cleavage furrow which where proposed to represent
had been made much earlier (reviewed in [47]), yet nothe apparatus of the ‘contractile ring’ ([52] and refer-
molecular connection had been made between the twoences therein). It was Schroeder, however, who, by dem-
beyond the observation that the actin ‘thin filaments’ ofonstrating that cytochalasin both disrupted this contrac-
muscle were similar in diameter to the ‘microfilaments’tile ring and abolished cytokinesis [52, 53], directly
observed in cells [64].implicated the filaments in cytokinesis and suggested
In a landmark paper, Spudich and Lin studied thea “purse string” mechanism for furrowing. This work,
effect of cytochalasin on purified actin and actomyosinof course, also suggested a mechanism of action for
from rabbit muscle [64]. These authors demonstratedcytochalasin with respect to the block of cytokinesis.
that cytochalasin could decrease the viscosity of solu-Morphologically similar microfilaments had already
tions of pure filamentous actin, thus revealing in onebeen observed in nondividing cells [54], although their
fell swoop that cytochalasin targets the actin protein ofrelationship to the filaments of the ring remained specu-
muscle, and actin therefore likely also comprises thelative [52]. Ishikawa et al. [55] used a technique for dec-
contractile ring and other cellular microfilaments. Thisorating muscle actin filaments for electron microscopy
supported the prevailing hypothesis that actomyosinusing a proteolytic fragment of the myosin protein to
assemblies controlled aspects of the motility of nonmus-probe the nature of microfilaments in nonmuscle cells.
The characteristic arrowhead pattern they observed in cle cells and led to an explosion in the use of cytocha-
Review
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structure in a various processes. Indeed, as Carter ob-
served in his original description of the activity of cyto-
chalasin:
By interfering with specific cell activities such as cyto-
plasmic cleavage and cell movement, they should prove
useful as research tools for investigating these important
aspects of cell biology. [44]
The identification of the latrunculin family of actin mo-
nomer binding drugs deserves mention for its particular
contribution to the study of the actin cytoskeleton of
yeast. Originally identified as a toxic agent in the marine
sponge Latrunculia magnifica, the latrunculins (A and
B) were shown to disrupt the actin cytoskeleton in mam-
Figure 3. PubMed Citations of Cytoskeletal Inhibitors malian tissue culture cells [74]. Based on these initial
The number of citations for each search term is plotted as a function observations, latrunculin was shortly thereafter shown
of year.
to interact directly with monomeric actin in a 1:1 com-
plex, preventing its incorporation into filaments [75].
Although actin is an essential gene in Saccharomyceslasin as a research tool for disrupting actin function (see
cerevisiae [76], temperature-sensitive mutants in the ac-Figure 3).
tin gene have allowed some phenotypic analysis of actinThese studies connecting actin, microfilaments, and
mutations on an approximately 1 hr time scale [77]. Thecytochalasin were reinforced by contemporary work on
use of latrunculin in S. cerevisiae, however, allowed athe fungal metabolite phalloidin. It was isolated in 1937
first look at the acute phase of actin perturbation. Withinas one of the toxic peptides derived from mushrooms of
minutes of addition, latrunculin caused the loss of fila-the Amanita genus [65], whose toxicity has been studied
mentous actin in a reversible manner [78]. Cytochalasin,since the early 1800s (reviewed in [66, 67, 68]). Morpho-
by contrast, had no effect, most likely due to cell perme-logical studies of intoxicated animals revealed only
ability issues [79]. Using latrunculin, then, allowed theacute liver toxicity associated with vacuolization of the
authors to demonstrate that even in the nonmotile yeastendoplasmic reticulum [69]. An important breakthrough
cell, the actin cytoskeleton exhibits dynamic de- andresulted from the demonstration that phalloidin could
repolymerization like in mammalian cells, suggestinginduce the formation of microfilament-like filamentous
that dynamicity of the actin cytoskeleton is a universalstructures both in vivo and in preparations of cyto-
phenomenon.plasmic membrane fragments [70]. Importantly, a non-
The rapid onset and effectiveness of latrunculin intoxic derivative of phalloidin, desmethylphalloinsulfox-
yeast has led to its continuing wide use in exploring theide, did not induce these structures [70]. Two years later,
role of the actin cytoskeleton of this organism in suchfollowing the lead of Spudich and Lin [64], it was shown
areas as cell polarity [80], spindle orientation [81], andthat phalloidin could drive the polymerization of mono-
endocytosis [82]. Indeed, the widespread use of latrun-meric G-actin from rabbit muscle [71]. This polymeriza-
culin when temperature-sensitive mutations also exist istion could be inhibited by preincubation with cytocha-
a testament to the advantages offered by small moleculelasin, and the phalloidin-induced filaments produced
inhibitors (see below). Latrunculin has also becomeboth in vitro and in vivo could, like conventional actin
more widely used in mammalian cells. The observationfilaments, be decorated with heavy meromyosin. Thus
that latrunculin and cytochalasin produce distinct ef-phalloidin, like cytochalasin, played an important role in
fects in mammalian cells (Figure 4; [83]) is indicative ofconnecting the morphologically defined microfilaments
different mechanisms of action. Whereas cytochalasinwith the muscle actin protein.
binds both monomeric actin and filament ‘barbed’ ends,
latrunculin binds exclusively to actin monomers, making
the interpretation of latrunculin experiments somewhatAdvances in Actin Biology Driven
by Chemical Inhibitors more straightforward [75, 84]. Furthermore, cytochalasin
B (but not cytochalasin D) was shown to also inhibitThe number of literature citations of phalloidin or cyto-
chalasin has increased steadily since the discovery of glucose uptake by cells [85, 86] raising questions of
specificity, whereas the identification of mutants in actintheir mechanism of action (Figure 3). Although the gen-
eral cell impermeability of phalloidin has limited its use that confer latrunculin resistance in S. cerevisiae have
strongly suggested that the interaction of latrunculinin live cells, an important development has been the
utilization of flourescently labeled phalloidin for staining and actin in yeast is highly specific [78]. Cytochalasin
and latrunculin are each, therefore, unique probes offilamentous actin in fixed tissues and cultured cells ([72];
Figure 4). Jasplakinolide, a natural product isolated from actin function offering distinct mechanisms of pertur-
bation.a marine sponge, also stabilizes actin polymers yet is
cell permeable and has been used in live cells to investi-
gate the importance of filament disassembly in, for ex- Small Molecules as Tools in Crystallography
Crystallographic analysis of cytoskeletal proteins isample, lamellipodial extension [73]. The cytochalasins
rapidly enter living cells, disrupt the actin cytoskeleton complicated by the tendency of individual subunits to
polymerize into filaments at high concentrations. This(see Figure 4), and have been used to implicate this
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Figure 4. Structure and Effect of Classical Actin-Perturbing Agents
B-SC-1 cells treated with 10.4 M cytochalasin B, 200 nM latrunculin B, or vehicle control were fixed and stained with rhodamine-conjugated
phalloidin.
difficulty has been overcome in the case of actin by curs proximal to the plasma membrane and that the
entire actin network of the growth cone translocateschemical modification of the actin monomer [87], by
cocrystallizing actin with monomer binding proteins that centripetally back toward the axon. Importantly, this po-
lymerization and retrograde actin flow from the leadingprevent polymerization [88, 89, 90, 91], and by the use of
the small molecule latrunculin [84]. Using the converse edge is now thought to drive protrusion during cell mi-
gration [98].approach, Nogales et al. [92] used taxol and zinc to
stabilize sheets of tubulin in order to derive an atomic
model of the  tubulin dimer. Thus, small molecules New Screens, New Molecules
The majority of the most widely used cytoskeletal inhibi-have also been important tools for investigating the mo-
lecular architecture of actin and tubulin at the atomic tors today are natural products that initially drew interest
for their toxicity or potential medicinal utility. The collec-level.
tive human experience can thus be seen as a rather
“low-throughput” screen for bioactive molecules in theIn and Out in the Blink of an Eye
Chemical inhibitors have illuminated cytoskeletal func- natural world. Recent advances in combinatorial chem-
istry and high-throughput bioassay screening, however,tion not only through the study of compound-treated
cells. Important observations have been made of cells promise to rapidly increase the speed and efficiency
of this process and allow it to be directed toward theduring the “washout” or recovery period when com-
pound-treated cells are washed into media lacking the identification of small molecules with a particular activ-
ity. The actin and tubulin networks of cells consist notinhibitor. Indeed, the rapid reversibility of colchicine and
nocodzole was instrumental in revealing the microtu- only of the filaments and tubules themselves. A large
number of regulatory and structural proteins, includingbule-nucleating role of the microtubule organizing cen-
ter (MTOC). Upon washout of cells treated with no- motors, crosslinkers, depolymerizers, and filament bun-
dlers, can act to create and organize these assemblies.codazole or colcemid, microtubules are observed to
preferentially regrow from this perinuclear structure, Several researchers have begun to conduct screens for
small molecules targeting components other than actinsuggesting that the MTOC plays a normal role in the
nucleation of new microtubules [93, 94, 95]. These ob- and tubulin themselves. New inhibitors and a few of
these new screens are presented below and are in-servations were confirmed using cold-induced depo-
lymerization of microtubules followed by rewarming [96]. tended to illustrate the diversity of target classes and
approaches.Paul Forscher used a similar approach using cytocha-
lasin to investigate actin dynamics in the neuronal
growth cone [97]. Time-lapse video images revealed that Motor Protein Inhibitors
The recent identification of the Eg5 kinesin inhibitoron addition of cytochalasin, the actin cytoskeletal matrix
within the growth cone disappeared by first receding monastrol demonstrates the success of using whole-
cell-based assays to identify inhibitors of the cytoskele-away from the plasma membrane as an intact unit at
a rate of 3–6 m/min (see Figure 5). On cytochalasin ton. Mayer et al. [99] screened for compounds that
would induce mitotic arrest in tissue culture cells aswashout, the matrix reappeared first at the plasma mem-
brane and widened and extended toward the rear of the assayed by an antibody to the mitotic form of the nucleo-
lin protein. Since compounds that perturb microtubulegrowth cone at an identical 3–6m/min. These observa-
tions strongly suggested that new actin assembly oc- dynamics (e.g., nocodazole and taxol) can cause mitotic
Review
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Figure 5. Demonstration that the Actin Network Exhibits Retrograde Flow from the Plasma Membrane, Where New Actin Polymerizes, Centri-
petally toward the Cell Body in Aplysia Neural Growth Cones
Reproduced from The Journal of Cell Biology, 1988, 107, 1505–1516 by copyright permission of The Rockefeller University Press. Time-lapse
differential interference contrast video images of a growth cone after treatment with 10 M cytochalasin. (A)–(E) represent 0, 0.5, 1, 3, and 9
min of treatment, respectively. The actin network is seen to recede from the plasma membrane at 3–6 m/min (arrowheads in B and C).
Cytochalasin was then removed from the culture media, and cells were allowed to recover for 1, 3, and 17 min (F–H, respectively). The border
of the new, advancing actin network (empty arrowheads in G) also migrates at 3–6 m/min toward the axon.
arrest, active compounds were subsequently count- motors is large and diverse [107], and small molecules
that can discriminate between members will allow de-erscreened to eliminate molecules that directly affect
microtubule dynamics in vitro. One of the resulting com- tailed study of their unique functions in vivo.
A conceptually different approach to chemical inhibi-pounds produced a remarkable reorganization of the
mitotic spindle of treated cells. Instead of bipolar spin- tion of motor proteins has now been used with both
kinesin and myosin motors. Pioneered by Shokat [108],dles, monastrol-treated cells produced monoastral
spindles. A similar phenotype had been previously ob- this method involves expression of mutated nucleotide
binding proteins with engineered sensitivity to a nucleo-served both in vitro [100] and in vivo [101] on inhibition
of the mitotic kinesin Eg5 using anti-Eg5 antibodies. tide analog. The first proof of principle of this approach
for motor proteins involved a single amino acid mutationIndeed, in vitro experiments showed that monastrol in-
hibited microtubule motility powered by Eg5, whereas in the nucleotide binding pocket of kinesin [109]. This
mutation conferred sensitivity to the nonhydrolyzeablea structurally related compound that did not cause
monoasters in cells did not [99]. ATP analog cyclopentyl-adenylyliminodiphosphate, which
does not inhibit the wild-type protein. Thus, these au-Importantly, monastrol appears to show remarkable
specificity despite its low micromolar IC50 against Eg5. thors demonstrated a new experimental approach for
the specific inhibition of motor proteins. Holt et al. [110]Microtubule arrays in interphase cells appear to be com-
pletely unaffected, and effects of monastrol are rapidly have recently utilized this approach to address the func-
tion of the myosin-1c protein in adaptation of the hairreversed on washout of the compound. The specificity,
reversibility, and cell permeability of monastrol promises cells in the sensory epithelium of the inner ear. A muta-
tion of the myosin-1c nucleotide binding pocket wasthat this compound will be an invaluable tool to help
reveal the functions of Eg5 during mitosis. Indeed, using generated that would accommodate an N6-modified
ADP analog but that would not prevent its utilization ofmonastrol it was shown that the motor activity of Eg5
was not required for its normal spindle localization [102]. ATP [111]. Sensory epithelia isolated from mice express-
ing the mutant protein behaved normally electrophysio-In addition, perturbation of spindle function by mon-
astrol allowed Kapoor et al. [103] to probe the spindle- logically. When exposed to the ADP analog, however,
a loss of the adaptive response to hair cell deflectionassembly checkpoint without directly affecting microtu-
bule dynamics. An Eg5 inhibitor with nanomolar affinity was observed, demonstrating a crucial role for myosin-
1c in hair cell adaptation.was recently reported [104], and this or related com-
pounds will be tested as anticancer drugs in humans.
Recently, two new cell-permeable myosin motor in- Signaling Protein Inhibitors
Using an approach intermediate between cell-basedhibitors were identified in pure protein screens for inhibi-
tors of skeletal muscle myosin II [105] and nonmuscle screens and pure protein assays, Peterson et al. [112]
screened for small molecules that would inhibit a signal-myosin II [106]. The myosin superfamily of actin-based
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ing pathway controlling the nucleation and polymeriza-
tion of actin filaments in a cytoplasmic extract. By
screening for inhibitors of an entire pathway, these au-
thors screened multiple potential targets, both known
and unknown, allowing the biology to dictate the best
targets. Interestingly, two inhibitors of a signal integrat-
ing protein, the neural Wiskott Aldrich Syndrome protein
(N-WASP), were identified using this screen ([112];
J.R.P., L. Bickford, A. Kim, M. Kirschner, and M. Rosen,
unpublished data). N-WASP exists in an autoinhibited
state that can be activated by binding to signaling mole-
cules such as active cdc42, Nck, or phosphatidylinositol
4,5-bisphosphate [113]. On binding its activators,
N-WASP undergoes a conformational change that
allows it to activate the Arp2/3 complex, an actin nucle-
ating protein complex [113]. Both of the inhibitors, 187-1,
a 14 amino acid cyclic peptide, and wiskostatin, an
N-alkylated carbazole derivative, appear to inhibit
N-WASP by stabilizing the autoinhibited conformation,
thus preventing subsequent activation of the Arp2/3
complex (Figure 6). The identification of two chemically
distinct inhibitors of N-WASP suggests that this protein
is not only an important signaling node but potentially
also an important locus for inhibitors of this pathway.
Conclusions
Why have chemical approaches to study the cytoskele-
ton been so successful? One answer must certainly be
the swift action of small molecules. Cytoskeletal re-
arrangements typically occur over seconds, a time scale
inaccessible to traditional genetic approaches but ad-
dressable by the rapid diffusion of small molecules. This
avoids the complications of cellular adaptation/com-
pensation that can arise when using genetic knockout
Figure 6. Inhibitors of N-WASP Block Actin Filament Assembly byapproaches. An alternative to the knockout of genes of
Stabilizing the Autoinhibited Conformation of N-WASPinterest is the use of temperature-sensitive mutants.
(A) Structures of two N-WASP inhibitors, the 14 amino acid cyclicThis approach sometimes allows relatively rapid protein
peptide 187-1 and wiskostatin.inactivation and also allows the study of the loss of
(B) Signaling molecules including Cdc42 bind N-WASP, relieving its
function of essential genes. Temperature shifts alone, intrinsic autoinhibition and exposing a C-terminal domain that can
however, have the potential for nonspecific perturbation bind and activate the Arp2/3 complex to nucleate a new actin fila-
[114]. Indeed, transcriptional profiling of Saccharo- ment. 187-1 and wiskostatin attenuate this signaling cascade by
stabilizing the autoinhibited conformation of N-WASP, antagonizingmyces cerevisiae has demonstrated “massive and rapid
activation by upstream signaling molecules (based on [112] andalterations in genomic expression” of wild-type strains
J.R.P., L. Bickford, A. Kim, M. Kirschner, and M. Rosen, unpublishedon temperature shift from 25 to 37C [115, 116]. The
data).
quick reversibility of many inhibitors allows acute tem-
poral control over the inhibition as well as investigation
of the ‘recovery phase.’ Additionally, the apparent target microtubule polymerization and/or stability [99, 117].
These results raise an important question: what makesspecificity shown by inhibitors like nocodazole and la-
trunculin allows almost genetic knockout-like inactiva- tubulin such a good drug target? Further study of the
structural basis for the binding and mechanism of actiontion of individual components of the complex cytoskele-
tal network. Finally, the functional roles of actin and of these inhibitors should help shed light on this issue.
In addition, the mitotic checkpoint may be sensitive totubulin appear to be broadly conserved across the eu-
karyotes. Therefore, the study of different experimental and amplify even subtle perturbations of the spindle.
Intriguingly, of the small molecule targets discussedsystems is greatly benefited by reagents that are neither
species- nor cell-type dependent. here (actin, tubulin, Eg5, muscle myosin, nonmuscle my-
osin, N-WASP), all are proteins that undergo reversibleMore speculatively, perhaps the cytoskeleton has
been well served with small molecule inhibitors simply conformational changes as part of their functional cy-
cles. Indeed, several of their inhibitors (latrunculin,because many of its components are “druggable.” A
remarkable number of small molecules have been identi- 187-1, wiskostatin) appear to act by blocking these con-
formational changes, suggesting that target “inhibitabil-fied that directly target microtubules [40]. In one unbi-
ased screen for compounds that would induce mitotic ity” and conformational flexibility may be related [84,
112]. In this context, it is interesting to note the lack ofarrest, 38% of the initial ‘hits’ proved to directly affect
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discovery to clinic—thirteenth Bruce F. Cain Memorial Awardsmall molecules that target the third major cytoskeletal
Lecture. Cancer Res. 55, 753–760.system, the ‘intermediate’ filaments. These structures
14. Fuchs, D.A., and Johnson, R.K. (1978). Cytologic evidence thatare thought to play predominantly a more rigid, struc-
taxol, an antineoplastic agent from Taxus brevifolia, acts as a
tural role, and their inherent stability, then, may be less mitotic spindle poison. Cancer Treat. Rep. 62, 1219–1222.
amenable to disruption by small molecules. 15. Schiff, P.B., Fant, J., and Horwitz, S.B. (1979). Promotion of
microtubule assembly in vitro by taxol. Nature 277, 665–667.The newly discovered inhibitors discussed above rep-
16. Heidemann, S.R., and Gallas, P.T. (1980). The effect of taxolresent only the tip of the iceberg of molecules yet to be
on living eggs of Xenopus laevis. Dev. Biol. 80, 489–494.identified using high-throughput screening technology.
17. Schiff, P.B., and Horwitz, S.B. (1980). Taxol stabilizes microtu-The evolving technology coupling combinatorially syn-
bules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 77,
thesized compound libraries with cytoskeleton-oriented 1561–1565.
screens, whether pure protein, extract-, or cell-based, 18. Vallee, R.B. (1982). A taxol-dependent procedure for the isola-
tion of microtubules and microtubule-associated proteinspromises to rapidly deliver to chemical genetics the
(MAPs). J. Cell Biol. 92, 435–442.equivalent of “saturation mutagenesis:” all cytoskeletal
19. Vale, R.D., Reese, T.S., and Sheetz, M.P. (1985). Identificationtargets screened versus a vast universe of small mole-
of a novel force-generating protein, kinesin, involved in micro-cules. The greatest challenge to the chemical approach tubule-based motility. Cell 42, 39–50.
remains the issue of specificity, ensuring that the pheno- 20. De Brabander, M., Van de Veire, R., Aerts, F., Geuens, G.,
type caused by a compound is indeed due the inhibition Borgers, M., Desplenter, L., and De Cree, J. (1975). In Microtu-
bules and Microtubule Inhibitors, M. Borgers and M. De Bra-of only its supposed “target.” Confirmation using inde-
bander, eds. (Amsterdam: North-Holland Publishing Com-pendent approaches will help address this concern. Yet
pany), pp. 509–521.nature has provided us with remarkable examples of
21. Hoebeke, J., Van Nijen, G., and De Brabander, M. (1976). Inter-
small molecules that appear to act on particular cy- action of oncodazole (R 17934), a new anti-tumoral drug, with
toskeletal proteins with exquisite specificity. This has rat brain tubulin. Biochem. Biophys. Res. Commun. 69,
been demonstrated directly by the fact that mutations 319–324.
22. Thyberg, J., and Moskalewski, S. (1985). Microtubules and theconferring resistance to taxol and latrunculin can be
organization of the Golgi complex. Exp. Cell Res. 159, 1–16.identified in the tubulin and actin genes, respectively
23. Mareel, M.M., and De Mets, M. (1984). Effect of microtubule[118, 77]. These encouraging examples suggest that if
inhibitors on invasion and on related activities of tumor cells.
we seek, we shall find. Int. Rev. Cytol. 90, 125–168.
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